-
Man has violated nature's laws of the sea
Time of Update: 2022-01-02
Scientists from Spain ICTA-UAB, Germany's Max Planck Institute for Science and Mathematics, Queensland University of Technology in Australia, Weizmann Institute of Science in Israel, and McGill University in Canada using advanced ocean observations and large-scale meta-analysis have shown that humans The impact has had the main consequences of larger marine species, and has also greatly changed the largest scale model of life-the model encompasses the entire marine biodiversity, from bacteria to whales .
-
Science: Map the global distribution of eukaryotic plankton biodiversity
Time of Update: 2022-01-02
This study highlights the huge differences in the geographic structure of plankton groups, which depend on their diversity, size, and ecology, which may be related to changes in sensitivity to local environmental conditions .
-
"Cell": How easy is it to transform from a "workman" to a "queen"?
Time of Update: 2022-01-02
▲A scythe ant opened its jaws to show its fierceness (picture source: reference [2]; Credit: Karl Glastad /Berger Lab, CC BY-SA)Although the change in behavior is huge, the switch that regulates this complex transition is surprisingly simple—just a single protein "turns on" and "turns off" different genes in the brain .
-
The technology for treating Alzheimer's disease has been certified as a breakthrough medical device by the FDA
Time of Update: 2022-01-02
On November 2, 2021, Renew Bioscience announced that a medical device named Cerezen has been granted breakthrough medical device designation by the US FDA for the treatment of mild cognitive impairment (MCI) caused by Alzheimer’s disease, and Alzheimer's type mild dementia .
-
Structural biology enters a new era: two prediction algorithms join forces to board "Science"
Time of Update: 2022-01-02
It is the different nature of the two sets of tools that give the research team the opportunity to combine the advantages of the two to screen for possible interacting proteins and predict their structure within the scope of the whole proteome .
-
Johnson & Johnson's Stelara Crohn's Disease and Ulcerative Colitis Trials Successfully
Time of Update: 2022-01-02
The trial results show that compared with second-line or third-line treatment, Stelara as a first-line treatment is associated with longer clinical remission or longer clinical response time in adult patients with moderate to severe active ulcerative colitis, including delaying the time for patients to undergo surgery .
-
TUV Rheinland issues carbon footprint certificate for JinkoSolar photovoltaic modules
Time of Update: 2022-01-02
Aiming at each stage of the product life cycle from "cradle to door", combined with domestic and international supply chain trends, Two types of solar energy modules have undergone carbon footprint verification .
-
Dark skin color after cupping means poor body?
Time of Update: 2022-01-02
The negative pressure in the tank causes the pathological products to be discharged from the skin pores, so as to achieve the purpose of adjusting the balance of yin and yang of the human body, enhancing physical fitness, stimulating essence, regulating qi and blood, and preventing and curing diseases .
-
Ou Jian cooperates with Heidelberg University in Germany to carry out peptide and cell therapy efficacy research
Time of Update: 2022-01-02
Frankfurt, Germany, October 28, 2021/PRNewswire/ - European Wellness Academy ("EWA"), the educational branch of European Wellness Biomedical Group ("EWG"), has signed an agreement An agreement to conduct joint scientific research on the rejuvenation efficacy of peptides, cell therapy, exosomes, and cell reprogramming in a mouse model of progeria .
-
The things that are not strange every day can help cure cancer?
Time of Update: 2022-01-02
Because of this feature, a new study in "Science-Progress" also reveals its medical value: arginine can be used as an adjuvant therapy to improve the effect of chemotherapy in patients with brain metastases .
-
Daiichi Sankyo Vanflyta + chemotherapy as the first-line treatment of FLT3-ITD positive AML significantly prolongs survival
Time of Update: 2022-01-01
The trial is evaluating the oral targeted anticancer drug Vanflyta (quizartinib) for the treatment of newly diagnosed adult patients with FLT3-ITD-positive acute myeloid leukemia (AML) .
-
Provide new options for people with poor vaccine effects
Time of Update: 2022-01-01
Today, AstraZeneca announced the latest results of its long-acting new coronavirus neutralizing antibody AZD7442 in two phase 3 clinical trials for the prevention and treatment of COVID-19 .
Retrieved November 18, 2021, from https:// -centre/press-releases/2021/new-analyses-of-two-azd7442-covid-19-phase-iii-trials-in-high-risk-populations-confirm-robust-efficacy-and-long-term-prevention .
-
Cell: SARS-CoV-2 variants similar to Delta variants can exacerbate the new crown pandemic
Time of Update: 2022-01-01
In a new study, researchers from the Chen Zengxi School of Public Health of Harvard University in the United States constructed a mathematical model and found that a SARS-CoV-2 variant with similar characteristics to the Delta variant---enhanced transmission and The ability to infect previously infected/vaccinated people --- will cause a more serious pandemic, resulting in more infections and breakthroughs than the SARS-CoV-2 variant that has one of these two characteristics alone Sexual infection/reinfection .
-
Shenzhou Cell: Recombinant New Coronavirus Vaccine Product of Holding Subsidiary Received Drug Clinical Trial Approval
Time of Update: 2022-01-01
SCTV01C is a recombinant new coronavirus Alpha+Beta mutant strain independently developed by Shenzhou Cell Engineering to address the problems of the first-generation domestic and foreign vaccines based on the original strain of the new coronavirus, such as the reduction of the neutralizing antibody titer and the protection rate of the mutant strain.
-
Materials Science of Chinese Medicine: Reduce the size of medicinal materials and enlarge the curative effect
Time of Update: 2022-01-01
The materials science of Chinese medicine proposed by Wu Shuilin's team is to use materials science methods to process Chinese herbal medicines into a kind of nano-level biological functional materials to enhance and improve the therapeutic effects of traditional Chinese medicine in various diseases .
-
Didn't even figure out what's in the cell. Research uses AI to find a large number of unknown intracellular proteins
Time of Update: 2022-01-01
Then AI needs to continue to study repeatedly, calculate and analyze the distance between protein and protein, and finally form a multi-scale integrated cell 1.
-
From EGFR-TKI iteration to see the dynamic changes of lung cancer clinical needs
Time of Update: 2022-01-01
Among them, afatinib was first approved for use in EGFR 19del/L858R mutant NSCLC patients, and then expanded to rare EGFR mutations and squamous non-small cell lung cancer; dacomitinib supplements the disadvantage of the first-generation drug due to insufficient brain penetration, and further Meet the clinical treatment options .
-
Xinmai Medical’s peripheral high-pressure balloon dilatation catheter product obtained the medical device registration certificate
Time of Update: 2022-01-01
At the same time, it is suitable for the post-expansion of balloon expandable stents or self-expanding stents in the peripheral vascular system .
-
Choose cold medicine for chronic diseases to avoid these "minefields"
Time of Update: 2022-01-01
People with nasal congestion and runny nose can use vasoconstrictor pseudoephedrine hydrochloride; fever and headache can use antipyretic analgesics paracetamol (paracetamol), ibuprofen; sneezing can choose chlorpheniramine and diphenhydramine with anti-allergic ingredients Etc.
-
Good news for patients with metastatic cancer of unknown primary tumor (R) may bring therapeutic benefits
Time of Update: 2022-01-01
is a microarray-based gene expression detection product that can assist in evaluating metastasis The origin of poorly differentiated and undifferentiated tumors in order to improve the treatment benefit of patients with metastatic carcinoma of unknown primary (CUP) .
